Researchers at Johns Hopkins, The Mayo Clinic, Harvard Medical School, Duke and others found in a study of 230 Alzheimer’s patients tracked over four years that psychotropic medications were associated with more rapid cognitive and functional decline, without neuropsychiatric improvements otherwise. The results will be published in an upcoming issue of Geriatric Psychiatry.
Abstract →Discuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.